Secret ingredient: nanoparticles aid bone growthJune 16, 2008In the first study of its kind, bioengineers and bioscientists at Rice University and Radboud University in Nijmegen, Netherlands, have shown they can grow denser bone tissue by sprinkling stick-like nanoparticles throughout the porous material used to pattern the bone. The research is available online and slated to appear in the journal Bone. It's the latest breakthrough from the burgeoning field of tissue engineering. The new discipline combines the latest research in materials science and biomedical engineering to produce tissues that can be transplanted without risk of rejection. To grow new bone, tissue engineers typically place bone cells on porous, biodegradable materials called scaffolds, which act as patterns. With the right chemical and physical cues, the cells can be coaxed into producing new bone. As the scaffold degrades, it is replaced by new bone.
"Ideally, a scaffold should be highly porous, nontoxic and biodegradable, yet strong enough to bear the structural load of the bone that will eventually replace it," said lead researcher Antonios Mikos, Rice's J.W. Cox Professor in Bioengineering, professor of chemical and biomolecular engineering and the director of Rice's Center for Excellence in Tissue Engineering. "Previous research has shown that carbon nanotubes give added strength to polymer scaffolds, but this is the first study to examine the performance of these materials in an animal model." In the experiments, the researchers implanted two kinds of scaffolds into rabbits. One type was made of a biodegradable plastic called poly(propylene fumarate), or PPF, which has performed well in previous experiments. The second was made of 99.5 percent PPF and 0.5 percent single-walled carbon nanotubes. Nanotubes are about 80,000th the width of a hair. While they are normally about a thousand times longer than they are wide, the researchers used shorter segments that have fared well in prior cytocompatibility studies. Half the samples were examined four weeks after implantation and half after 12 weeks. While there was no notable difference in performance at four weeks, the nanotube composites exhibited up to threefold greater bone ingrowth after 12 weeks than the PPF. Furthermore, the researchers found the 12-week composite scaffolds contained about two-thirds as much bone tissue as the nearby native bone tissue, while the PPF contained only about one-fifth as much. Mikos said the nanocomposites performed better than anticipated. In fact, the results indicate that they may go beyond passive guides and take an active role in promoting bone growth. "We don't yet know the exact mechanism of this enhanced bone formation, but we have intensive studies under way to find out," Mikos said. "It could be related to changes in surface chemistry, strength or other factors." Co-authors on the paper include Rice former Ph.D. graduate student Xinfeng Shi, now a research scientist at Bausch & Lomb, and former postdoctoral fellow Balaji Sitharaman, now an assistant professor of biomedical engineering at State University of New York at Stony Brook; Lon Wilson, professor of chemistry at Rice; and John Jansen, Frank Walboomers, Hongbing Liao and Vincent Cuijpers, all of Radboud University Nijmegen Medical Center. The research was funded by the National Institutes of Health, the National Science Foundation, the Robert A. Welch Foundation, and Rice's J. Evans-Attwell Postdoctoral Fellows Program. Rice University | |||||||||||||||||||||
|
Related Bone Tissue Current Events and Bone Tissue News Articles Merck's odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study Two-year data from a Phase IIB study of odanacatib (formerly MK-0822), an investigational, selective cathepsin-K inhibitor in development for the treatment of osteoporosis by Merck & Co., Inc., demonstrated dose- dependent increases in bone mineral density (BMD) at the total hip, lumbar spine and femoral neck fracture sites and decreased indices of bone resorption compared to placebo in postmenopausal women with low BMD. Hydrogels provide scaffolding for growth of bone cells Hyaluronic hydrogels developed by Carnegie Mellon University researchers may provide a suitable scaffolding to enable bone regeneration. The hydrogels, created by Newell Washburn, Krzysztof Matyjaszewski and Jeffrey Hollinger, have proven to encourage the growth of preosteoblast cells, cells that aid the growth and development of bone. Doctoral student Sidi Bencherif will present this research, Sunday, Aug. 17 at the 236th national meeting of the American Chemical Society in Philadelphia. Toothpick: New molecular tag IDs bone and tooth minerals Enlisting an army of plant viruses to their cause, materials researchers at the National Institute of Standards and Technology (NIST) have identified a small biomolecule that binds specifically to one of the key crystal structures of the body-the calcium compound that is the basic building block of teeth and bone. With refinements, the researchers say, the new molecule can be a highly discriminating probe for a wide range of diagnostic and therapeutic applications related to bones and teeth. Simple ultrasound exam may predict osteoporosis risk An ultrasound exam of the heel may be able to predict if a woman is at heightened risk for fractures due to osteoporosis, according to a new multicenter study being published in the July issue of the journal Radiology. Surgeon operates to rescue chimp with rare deformity An orthopaedic surgeon at the University of Liverpool has performed a groundbreaking operation on a chimp in Cameroon to correct a deformity more commonly seen in dogs. Rice and UT-Houston join DOD push for regenerative medicine The Department of Defense (DOD) today announced that Rice University and the University of Texas Health Science Center at Houston will spearhead the search for innovative ways to quickly grow large volumes of bone tissue for craniofacial reconstruction for soldiers wounded in Iraq and Afghanistan. NYU dental professor discovers biological clock Why do rats live faster and die younger than humans? A newly discovered biological clock provides tantalizing clues. Engineers Use Blood's Hydrodynamics to Manipulate Stem, Cancer Cells A tiny, implantable device has pulled adult stem cells out of a living rat with a far greater purity than any present technique. Popular osteoporosis drugs triple risk of bone necrosis A University of British Columbia and Vancouver Coastal Health Research Institute study has found that a popular class of osteoporosis drugs nearly triples the risk of developing bone necrosis, a condition that can lead to disfigurement and incapacitating pain. Stem cells make bone marrow cancer resistant to treatment Scientists at the Johns Hopkins Kimmel Cancer Center say they have evidence that cancer stem cells for multiple myeloma share many properties with normal stem cells and have multiple ways of resisting chemotherapy and other treatments. More Bone Tissue Current Events and Bone Tissue News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||